Institutional investors purchased a net $866.8 thousand shares of RGEN during the quarter ended September 2017, and now own 97.61% of the total float, a percentage that is typical for companies in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
THE VANGUARD GROUP, INC. Bought 844.8 Thousand shares of Repligen Corp
BLACKROCK FUND ADVISORS Bought 399.1 Thousand shares of Repligen Corp
REDWOOD INVESTMENTS LLC Bought 195.0 Thousand shares of Repligen Corp